Welcome

Sign out Have a question? We're here to help

Copyright © 2019 InvestorPlace Media, LLC. All rights reserved. 9201 Corporate Blvd, Rockville, MD 20850.

Ra Pharmaceuticals Inc (RARX)

$29.42 0.70 (2.44%)

17:58 EDT RARX Stock Quote Delayed 15 Minutes

Volume:

Previous Close $29.42

Market Cap 950.64M

PE Ratio -11.67

EPS -2.52

Volume (Avg. Vol.) 394,800

Day's Range 28.81 - 29.88

52-Week Range 10.02 - 36.96

Dividend & Yield N/A (N/A)

RARX Stock Predictions, Articles, and Ra Pharmaceuticals Inc News

From InvestorPlace
From the Web

5 Clinical-Stage Biotech Stocks to Buy

By Aaron Levitt, InvestorPlace Contributor Feb 25, 2019

There are plenty of potential in clinical-stage biotech stocks. Here are five with some wonderful catalysts.

5 Clinical-Stage Biotech Stocks to Buy Under $10

By Aaron Levitt, InvestorPlace Contributor May 29, 2018

Clinical-stage biotech stocks offer plenty of promise to investors looking to take on some risk. Here are five to buy today.

RBC sees 36% upside in Gilead in premarket analyst action

From Seeking Alpha Jul 29, 2019

KalVista Pharmaceuticals (NASDAQ:KALV) initiated with Outperform rating and $31 (83% upside) price target at SVB Leerink.Bellicum Pharmaceuticals (NASDAQ:BLCM) resumed with Outperform rating and $4 (1

Ra Pharma prices stock offering at $32.50; shares down 2% premarket

From Seeking Alpha Jul 24, 2019

Ra Pharmaceuticals (NASDAQ:RARX) slips 2% premarket on light volume in response to its public offering of 4M common shares at $32.50 per share. Underwriters over-allotment is an additional 600K shares

60 Biggest Movers From Yesterday

From Benzinga Jul 24, 2019

Gainers Hoth Therapeutics, Inc. (NASDAQ: HOTH) shares gained 58.8% to close at $6.75 on Tuesday. Therapix Biosciences Ltd. (NASDAQ: TRPX) shares surged 47.8% to close at $3.40...

45 Stocks Moving In Tuesday's Mid-Day Session

From Benzinga Jul 23, 2019

Gainers Therapix Biosciences Ltd. (NASDAQ: TRPX) shares climbed 44.8% to $3.3301 after the company said Tuesday that it has signed a letter of intent for a merger with the...

25 Stocks Moving In Tuesday's Pre-Market Session

From Benzinga Jul 23, 2019

Gainers Achieve Life Sciences, Inc. (NASDAQ: ACHV) shares rose 26.3% to $2.35 in pre-market trading. Achieve Life Sciences extended collaboration with NIH to advance the...

The Daily Biotech Pulse: Acadia Schizophrenia Drug Fails, Viveve Plummets, Eisai Gets Breakthrough Therapy Designation

From Benzinga Jul 23, 2019

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on July 22) Acasti Pharma Inc (...

Navellier Ratings

Powered by Portfolio Grader

Total Grade

A

Strong Buy

Free Report

10 Stocks Set for Monster Growth

He found Apple at $4… Oracle at $6… Amazon at $40… Now legendary growth investor Louis Navellier is giving away his latest Research Report — for FREE!

Download your FREE COPY!